Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imad Kassis

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Archives of Pediatrics & Adolescent Medicine|November 3, 2010
Hospitalization of children with influenza A(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter surveyMichal Stein, Diana Tasher, Daniel Glikman, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal diseaseHyoung Jin Kang, Antonio C Arrieta, Catharina Dhooge, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionRonen Ben-Ami, Keren Olshtain-Pops, Michal Krieger, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Archives of Pediatrics & Adolescent Medicine|November 3, 2010
Hospitalization of children with influenza A(H1N1) virus in Israel during the 2009 outbreak in Israel: a multicenter surveyMichal Stein, Diana Tasher, Daniel Glikman, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2026
Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal diseaseHyoung Jin Kang, Antonio C Arrieta, Catharina Dhooge, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2012
Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionRonen Ben-Ami, Keren Olshtain-Pops, Michal Krieger, et al.
Pageof 10